CytomX Therapeutics (CTMX) Stock Chart & Stock Price History $0.80 +0.04 (+5.90%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$0.81 +0.01 (+1.00%) As of 05/2/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CytomX Therapeutics Stock Price Performance 5 Day Performance+13.29%1 Month Performance+47.67%3 Month Performance-4.54%6 Month Performance-23.62%Year-To-Date Performance-22.14%1 Year Performance-81.90% Receive CTMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CTMX Stock Chart for Sunday, May, 4, 2025 CTMX Chart by TradingView CytomX Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$0.76$0.80+5.90%$0.83$0.761.42 million shs$64.24 million05/01/2025$0.74$0.76+1.75%$0.77$0.72716,246 shs$60.66 million04/30/2025$0.65$0.74+14.23%$0.74$0.631.65 million shs$59.62 million04/29/2025$0.71$0.65-7.95%$0.72$0.641.98 million shs$52.19 million04/28/2025$0.71$0.71-0.30%$0.77$0.703.97 million shs$56.70 million04/25/2025$0.77$0.71-7.29%$0.77$0.70715,524 shs$56.87 million04/24/2025$0.73$0.77+4.88%$0.77$0.68785,239 shs$61.34 million04/23/2025$0.74$0.73-0.80%$0.78$0.72682,809 shs$58.49 million04/22/2025$0.75$0.74-1.84%$0.78$0.731.23 million shs$58.96 million04/21/2025$0.66$0.75+14.31%$0.77$0.651.74 million shs$60.07 million Get the Latest News and Ratings for CTMX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$0.66$0.66$0.67$0.61575,360 shs$52.55 million04/17/2025$0.63$0.66+4.18%$0.67$0.61575,360 shs$52.55 million04/16/2025$0.63$0.63-0.29%$0.65$0.61580,392 shs$50.44 million04/15/2025$0.61$0.63+4.19%$0.68$0.611.17 million shs$50.58 million04/14/2025$0.53$0.61+13.82%$0.63$0.531.27 million shs$48.55 million04/11/2025$0.49$0.53+7.66%$0.54$0.48845,659 shs$42.65 million04/10/2025$0.50$0.49-1.14%$0.52$0.48744,817 shs$39.62 million04/09/2025$0.46$0.50+9.93%$0.52$0.431.50 million shs$40.07 million04/09/2025$0.46$0.50+9.93%$0.52$0.431.50 million shs$40.07 million04/08/2025$0.43$0.46+5.47%$0.48$0.451.26 million shs$36.45 million04/08/2025$0.43$0.46+5.47%$0.48$0.451.26 million shs$36.45 million04/07/2025$0.46$0.43-5.29%$0.47$0.402.31 million shs$36.49 million04/04/2025$0.54$0.46-16.11%$0.55$0.452.04 million shs$36.49 million04/03/2025$0.61$0.54-10.78%$0.60$0.541.23 million shs$43.50 million04/02/2025$0.58$0.61+4.95%$0.62$0.56907,263 shs$48.76 million Related Companies Bright Minds Biosciences Stock Chart Humacyte Stock Chart Protalix BioTherapeutics Stock Chart Kodiak Sciences Stock Chart Acelyrin Stock Chart Aardvark Therapeutics Stock Chart Prime Medicine Stock Chart SOPHiA GENETICS Stock Chart Neurogene Stock Chart CARGO Therapeutics Stock Chart Receive CTMX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CytomX Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTMX) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CytomX Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CytomX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CTMX Stock Free CTMX Stock Alerts